Parkside Investments LLC reduced its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 1.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,070 shares of the medical research company’s stock after selling 375 shares during the period. Thermo Fisher Scientific comprises 2.3% of Parkside Investments LLC’s portfolio, making the stock its 14th largest position. Parkside Investments LLC’s holdings in Thermo Fisher Scientific were worth $3,676,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Sharkey Howes & Javer increased its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the last quarter. Beacon Trust Co. increased its stake in shares of Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock worth $341,000 after buying an additional 12 shares during the last quarter. Dumont & Blake Investment Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock worth $849,000 after buying an additional 15 shares during the last quarter. Reinhart Partners Inc. increased its stake in shares of Thermo Fisher Scientific by 0.6% in the second quarter. Reinhart Partners Inc. now owns 3,430 shares of the medical research company’s stock worth $598,000 after buying an additional 20 shares during the last quarter. Finally, Azimuth Capital Management LLC increased its stake in shares of Thermo Fisher Scientific by 0.8% in the first quarter. Azimuth Capital Management LLC now owns 3,210 shares of the medical research company’s stock worth $493,000 after buying an additional 25 shares during the last quarter. 83.36% of the stock is currently owned by institutional investors and hedge funds.

In related news, SVP Gregory J. Herrema sold 30,000 shares of the company’s stock in a transaction on Wednesday, August 2nd. The stock was sold at an average price of $176.02, for a total value of $5,280,600.00. Following the completion of the transaction, the senior vice president now directly owns 67,016 shares in the company, valued at $11,796,156.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction on Friday, August 18th. The shares were sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the transaction, the director now owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The disclosure for this sale can be found here. Insiders sold 52,738 shares of company stock valued at $9,302,112 over the last 90 days. 0.49% of the stock is currently owned by corporate insiders.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 188.30 on Friday. The firm’s 50-day moving average is $181.07 and its 200 day moving average is $171.15. The company has a market cap of $73.46 billion, a price-to-earnings ratio of 32.80 and a beta of 1.05. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The business had revenue of $5 billion during the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. Thermo Fisher Scientific’s revenue was up 10.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.03 earnings per share. Equities analysts expect that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be paid a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is 10.45%.

A number of analysts recently issued reports on the stock. Deutsche Bank AG set a $200.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Wells Fargo & Company restated an “outperform” rating and issued a $200.00 price target (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. Bank of America Corporation restated a “buy” rating and issued a $210.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Finally, Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. One investment analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $194.33.

COPYRIGHT VIOLATION NOTICE: “Parkside Investments LLC Sells 375 Shares of Thermo Fisher Scientific Inc (TMO)” was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.watchlistnews.com/parkside-investments-llc-sells-375-shares-of-thermo-fisher-scientific-inc-tmo/1584052.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.